The vagus nerve is the body's primary neural regulator of systemic inflammation. Recent 2026 research confirms its central role via the cholinergic anti-inflammatory pathway.
The mechanism involves efferent vagal fibers releasing acetylcholine within the spleen. This neurotransmitter binds to α7 nicotinic receptors on macrophages, effectively suppressing NF-κB signaling.
This inhibits pro-inflammatory cytokines like TNF-α and IL-6 while preserving essential antibacterial responses. It prevents cytokine storms without inducing broad immunosuppression.
Trials in rheumatoid arthritis patients showed a 68% reduction in serum TNF-α. C-reactive protein levels fell by 52%, demonstrating significant clinical efficacy and dose-dependent control.
Bioelectronic medicine is redefining immune health. We are entering an era of precise, neural-based control over inflammatory homeostasis.